VICTORIA FLICK: Open Payments
NPI 1639821622 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 29 payments from 15 companies in 2025. Trend: 2023 $832 · 2024 $376 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $190 |
| ABBVIE INC. | 5 | $99 |
| Novo Nordisk Inc | 4 | $75 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| Dendreon Pharmaceuticals LLC | 1 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Exact Sciences Corporation | 2 | $33 |
| Medtronic, Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: Nubeqa, Ozempic, VRAYLAR, GEMTESA, BOTOX, PROVENGE, FANAPT, ALTAVIVA.
Industry payments across IN — which companies pay providers there.
